ArticleEFSA journal. European Food Safety Authority2026
Considerations on the risk assessment of genetically modified plants containing transformation events stacked by conventional crossing.
Article in EFSA journal. European Food Safety Authority, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Considerations on the risk assessment of genetically modified plants containing transformation events stacked by conventional crossing.EFSA journal. European Food Safety Authority · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following a mandate from EFSA, the EFSA Panel on Genetically Modified Organisms (GMO Panel) addressed the food and feed risk assessment of genetically modified plants containing stacked transformation events ('stacks'). The GMO Panel examined the experience gained in the assessment of stacks in the last 20 years. Based on this, the GMO Panel concluded that under specific conditions, field trials for comparative analysis may not always be required for the assessment of stacks and a derogation may be considered. The conditions are: all the events combined in the stack should express traits through newly expressed proteins (NEPs) and these should not be metabolic modifiers. Under the same conditions and in the absence of interactions affecting NEP expression levels, a derogation from current requirements for dietary exposure assessment may also be considered. The GMO Panel also proposes improvements for applicants regarding the presentation of molecular characterisation data for stacks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.